Laxmi Organic Faces Pressure; Analyst Retains 'Reduce'

CHEMICALS
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Laxmi Organic Faces Pressure; Analyst Retains 'Reduce'
Overview

Laxmi Organic Industries reported a challenging third fiscal quarter ending December 31, 2025, with revenues declining 8.6% year-on-year to ₹7.2 billion. The Essential Chemicals segment saw its EBITDAM turn negative at -5.1%, impacted by raw material price compression. The Specialty Chemicals segment revenue dropped 30%, attributed to product phasing out. Analyst firm Prabhudas Lilladher maintained its 'Reduce' rating, citing ongoing pressures and a valuation of 33x FY28E EPS, setting a target price of ₹125. The stock has fallen significantly year-to-date, hitting a 52-week low.

Prabhudas Lilladher Maintains Cautious Stance on Laxmi Organic Industries

Laxmi Organic Industries' stock experienced significant pressure, touching a 52-week low on January 30, 2026, following the release of its third-quarter fiscal year 2026 (Q3FY26) financial results. The company reported consolidated revenue of ₹7.2 billion, a year-on-year decrease of 8.6%, reflecting a challenging operational environment. This performance led Prabhudas Lilladher to reiterate its 'Reduce' rating on the stock, maintaining a target price of ₹125 based on a 33x FY28E Earnings Per Share (EPS) valuation. The stock's year-to-date performance has been weak, falling approximately 34% over the past year, signaling investor concern. [cite: input, 20]

Essential Chemicals Squeezed by Margin Compression

The company's core Essential Chemicals segment, which accounts for 70% of its total revenue, saw a 6% year-on-year decline. Its Earnings Before Interest, Taxes, Depreciation, and Amortization for the segment (EBITDAM) fell to -5.1%, a substantial 730 basis point drop. This downturn was primarily driven by declining prices of acetic acid, a key raw material, which compressed the profit margins for ethyl acetate, a product making up 80-85% of the segment's output. Ethyl acetate spreads are expected to remain under pressure in the near term, according to the report. [cite: input]

Specialty Chemicals Hit by Product Lifecycle and Campaign Sales

Revenue in the Specialty Chemicals segment plummeted by 30% year-on-year. This sharp decline was attributed to the planned phase-out of a product that contributed approximately 10% to the segment's portfolio. Furthermore, the absence of sales from campaign products, which were present in the previous fiscal year's Q3, exacerbated the revenue drop. The company anticipates launching a replacement for the phased-out product by the fourth quarter of FY26. [cite: input]

The Fluorochemicals segment, a strategic expansion area for the company following the acquisition of Miteni S.p.A. assets, remains in its early ramp-up phase. Management projects achieving between 40% and 60% of its ₹2 billion peak revenue potential within FY26. [cite: input, 25, 31] The company's entry into fluorochemicals, using acquired Italian plant technology, has attracted scrutiny regarding environmental regulations and the legacy of the Miteni facility in Italy.

Mixed Demand Trends and Sector Headwinds

On the demand side, the company is navigating a varied market. Sub-segments such as pharmaceuticals and printing & packaging demonstrated stable quarter-on-quarter trends. However, demand from the agrochemical sector remained moderate, while the paints and coatings industry continued to show weakness. These mixed demand signals compound the pressure from raw material price volatility and internal product adjustments. [cite: input]

The broader Indian specialty chemicals sector, while robust with projected growth, is currently facing headwinds. Factors like pricing pressures from China and elevated channel inventories impacted performance in FY2024, though an improvement has been noted in YTD FY2025 as inventory levels normalize. However, muted volume recovery persists amid high interest rates and soft global prices, with the overall chemical sector's performance remaining tied to the global economic outlook.

Market Performance and Outlook
Laxmi Organic Industries' market capitalization stood at approximately ₹3,932 crore as of January 30, 2026, with its P/E ratio trading around 49.4x. The stock's recent sharp decline has led to technical indicators suggesting a 'Strong Sell' signal. While the stock showed some resilience, recovering from intraday lows, the fundamental pressures highlighted by the Q3FY26 results, coupled with margin compression in key products and ongoing segment transitions, suggest continued caution. Competitors in the ethyl acetate market include IOLCP, Jubilant Ingrevia, and Prakash Chemicals International, while the specialty chemicals space features larger players like Pidilite Industries and Gujarat Fluorochemicals.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.